Abstract
Introduction
Healthcare interventions are typically complex 1 and involve two broad interacting categories of components: 1. clinical components, i.e., the clinical materials or equipment of the intervention and related features and 2. associated behavioural aspects i.e., the actual behaviours required to deliver the intervention in practice. Healthcare interventions are often specified clinically without explicitly addressing associated behavioural aspects required for successful delivery 2, 3 . Thus, interventions may be implemented differently across sites, potentially leading to variable effectiveness and resultant consequences for patient outcomes.
The need to fully describe healthcare interventions has been widely recognised, together with the need to report interventions in such a way as they could be directly replicated by others 4 .
Selective decontamination of the digestive tract (SDD) is an intervention that has been
shown to reduce hospital acquired infection rates and mortality in critically ill patients [5] [6] [7] .
SDD involves the application of antibiotics and antifungals to the mouth, throat and stomach combined with a short course of intravenous antibiotics 8 . Despite considerable evidence supporting the benefit of SDD [5] [6] [7] , adoption internationally is low 9, 10 . Amongst proposed reasons for this lack of adoption are controversies surrounding prophylactic use of antibiotics and associated risk of antibiotic resistance 11, 12 and purported difficulty of SDD implementation and delivery 13 .
Considerable variation exists in the clinical components of SDD evaluated in trials and used in clinical practice. A recent systematic Cochrane review noted that trials used different SDD protocols and investigators use different definitions for SDD 6 . In addition, behaviours related to the delivery of SDD have not been systematically described in the literature. As such, a standardised and fully specified protocol outlining both clinical components and associated behavioural aspects of SDD implementation and delivery in practice does not exist but could be very beneficial in both widespread clinical adoption and future effectiveness or implementation trials.
This study sought to describe the clinical components and associated behaviours related to SDD implementation and delivery in clinical practice.
Methods

Study Design
An in-depth multi-methods study design 14 was used in two UK intensive care units (ICUs) where SDD was routinely administered -with the 'site' (unit of analysis) consisting of an ICU. Data were collected from three sources: direct observation of SDD delivery at the bedside; face-to-face semi-structured interviews with clinicians responsible for implementing and/or delivering SDD; and systematic assessment of written documentation (e.g., SDD protocols, training documents) ( Figure 1 ).
___________________________Figure 1___________________________
Sampling and recruitment
All UK ICUs delivering SDD, identified from a recent national SDD survey 9 , or known by the study investigators to deliver SDD were deemed eligible for inclusion (15 ICUs) . Two ICUs were purposively selected to represent recent and more remote lengths of time since SDD adoption and different geographical locations (i.e. geographically dispersed ICUs to ensure different organisational profiles). For interviews we recruited a purposive sample of clinicians based on profession (i.e. intensivists, medical microbiologists, specialist clinical pharmacists and ICU nurses) and involvement in the implementation and/or delivery of SDD. This study was classified as service evaluation by the Research Ethics Committee (10/MRE00/32) and was deemed by them not to require ethical approval. All participants observed and interviewed were aware of the study purpose and provided verbal consent prior to data collection.
Materials
Observations were conducted using an investigator-designed form to record all behaviours relating to 'real time' delivery of SDD. Additionally, the context (i.e. the physical environment where behaviours were performed), timing of procedures and physical presence of healthcare providers at time of delivery were recorded.
Semi-structured face-to-face clinician interviews were conducted in the study hospitals using a topic guide with pre-specified prompts to ensure consistent coverage of key issues including behaviours relating to SDD implementation and SDD delivery as well as barriers and facilitators of described behaviours.
Lastly, written documentation relating to SDD implementation and delivery (e.g.
SDD protocols, training documents) were provided by the participating ICUs for systematic analysis.
Procedure
Data collection commenced with observation of SDD delivery performed by various ICU nurses to different patients at the bedside. Semi-structured interviews were conducted in parallel with observations. Observed nurses were included in the interview sample to gain an in-depth understanding of observed behaviours. With participants' permission, interviews were audio-recorded, transcribed verbatim and anonymised. Written documentation from each ICU was examined following completion of all observations and interviews to minimise researcher bias during these stages.
Analysis
Data from the three sources were analysed within-site to describe the clinical components and behavioural aspects of delivery and synthesised across-site to identify emergent themes describing SDD implementation and delivery in context. The analytical process was guided by the study aims that included identification of the clinical components and behavioural aspects of SDD and exploration of the implementation and delivery of SDD in practice.
The three data sources were analysed separately and in reverse order to data collection ( Figure 1 14 .
To identify features of SDD implementation and delivery across units, a thematic analysis of the interview data was conducted using a framework approach 16 . This involved coding the data for emergent themes relating to the behaviours and clinician groups involved.
A single researcher (SUD) coded the data, a second researcher (ED) independently coded randomly selected portions of the dataset to identify clinical components and associated behavioural aspects and three researchers (MP, JJF, LR) provided critical comments on analyses drafts.
Results
Site 1 implemented SDD 3.5 years prior to this study in response to increased hospital acquired infection rates and was the most recent adopter of SDD in the UK. 
SDD Clinical Components and Associated Behavioural Aspects
Protocols documenting the specific clinical behaviours required for drug preparation and administration in the two ICUs are detailed in Table 1 , demonstrating the degree of clinical complexity and also the variation encountered in clinical components of SDD. Documentation listed 9 different medications and a total of 13 different preparations as part of SDD in the two sites (Table 1) . Several behaviours directly relevant for drug administration were identified in examined documentation.
___________________________Table 1___________________________
Aside from clinical components and associated behavioural aspects directly relevant to SDD delivery, documents from both sites revealed several additional delivery behaviours performed by multiple clinicians in various clinical and environmental contexts ( Table 2 ). To complement understanding of associated behavioural aspects that are important in SDD delivery but not specifically mentioned in the examined documentation, Table 3 outlines additional delivery behaviours identified through interviews and observations. Behaviours outlined in Table 2 
___________________________Tables 2 and 3___________________________
Participant interviews were provided most data relating to behavioural aspects; 49 components were identified through interviews, 22 in documentation and 12 via observations. Each data source gave rise to unique behaviours not mentioned in other sources, confirming the added value of analysing multiple information sources (28, 7 and 4 unique behavioural aspects for interviews, documentation and observations, respectively). Twenty-nine and 9
behavioural aspects, respectively, were unique to the two sites. Twenty-six behavioural aspects were common across ICUs, being identified in at least one data source for each site.
SDD Implementation and Delivery
Based on our analysis, SDD implementation and delivery was conceptualised as a complex procedure consisting of four overlapping processes each involving specific behaviours: adoption, operationalisation, provision and surveillance. Adoption concerned the decision to introduce SDD; operationalisation referred to the processes required to introduce SDD in to clinical practice. SDD provision included actions involved in delivery of the clinical components. Surveillance, mentioned in both sites, provided the foundation for adoption, operationalisation and provision by checking that SDD was effective in preventing infection.
Adoption & Operationalisation
For adoption, we identified that actions often occurred at the organisational and team level involving organisational and group processes as well as individual actions. As the implementation process moved from adoption to operationalisation, more behaviours emerged that were performed by individual staff (Tables 2 and 3 ). Although operationalisation was complete following SDD introduction, elements of operationalisation continued due to clinician staff turnover (e.g., although SDD was a standard procedure within the ICUs, the low national baseline adoption meant that additional training for clinicians new to these ICUs and SDD delivery was required).
Provision of SDD
Three themes emerged from the interviews on SDD provision: complexity/difficulty, protocol adaptation in practice and facilitators and barriers.
Complexity / difficulty
Reflecting the theme of complexity one intensivist and several nurses reported that SDD provision represented additional and time consuming work leading to unpopularity with staff. When examining the sequencing and flow of actions, we identified some evidence of complexity such as multiple clinicians being involved in managing various behaviours within multiple clinical and environmental contexts using a range of materials delivered in specific sequences in a continuing flow of action (see Box 1 for quotations). However, most nurses and doctors refuted the idea that SDD was complex and time consuming stating that SDD provision was performed effortlessly (see Box 1 for quotations). Low complexity / difficulty of SDD was supported by observational data that indicated administration of clinical components took no longer than 5 minutes, and often less, and was performed in a swift sequence of actions. It is important to note, however, that these were highly practised actions and may require considerable skill development to achieve this high level of expertise.
____________________________Box 1____________________________
Protocol adaptation in practice
Protocol adaptation in SDD delivery was noted in observational and interview data.
Preparation of antibiotics/antifungals varied suggesting some deviation from recommended practice. A further adaptation was evident in the provision of SDD oral components such as different ways of applying oral drug components and timing with other nursing interventions such as oral hygiene. Authorisation of SDD involved multiple staff and deviation from recommended practice was noted. Although documentation indicated patients should be routinely commenced on SDD, this was not always the case, due to more pressing clinical concerns. As a result, multiple layers of control to ensure protocol adherence were described (see text box 2 for quotations).
____________________________Box 2____________________________
Facilitators and barriers
Various facilitators and barriers to SDD delivery were evident across both sites (Box 3). One facilitating factor frequently reported was 'dovetailing' of SDD with other established and routine procedures. Thus, intensivists might include SDD delivery behaviours as part of the admission process. Nurses might include SDD as part of oral hygiene or other activities, and microbiologist and pharmacists dovetailed SDD actions within ward rounds. Dovetailing was evident in multiple interviews and in documentary data on SDD provision for oral hygiene. Although barriers were commonly reported during interviews in response to specific prompts, these were often referred to as minor inconveniences, rather than significant obstacles to SDD delivery (see text box 3 for quotations).
____________________________Box 3____________________________
Infection Surveillance
Surveillance was specified in documentation outlining the SDD protocol in one of the sites, but not in the other, where it was part of the wider regimen to combat hospital acquired infections. Despite these differences, surveillance was integral to the provision of SDD, and included the performance of multiple behaviours of various clinicians in several clinical and environmental contexts.
Discussion
In line with frameworks for intervention development 1 and description, 4 this study is the first to formally seek to describe the full clinical components and associated behavioural aspects of SDD and to describe how they impact on SDD implementation and delivery in practice. There are several advantages of describing an intervention behaviourally alongside clinical descriptions. First, it demonstrates procedural complexity and the situations in which complexity may be experienced. This information has direct relevance to clinicians and hospital decision-makers considering implementation of particular healthcare interventions. It also can inform the scale and content of implementation strategies to facilitate diffusion and adoption within specific contexts 17 . Second, behavioural specification identifies potential areas where behavioural variation in practice may occur and thus allows prior specification of acceptable limits of protocol adaptation. Thirdly it can identify whether formal training for, and monitoring of, adherence to an expected standard of intervention delivery will be required. Fourthly, it may identify training needs to facilitate adherence to an expected standard. Finally, behaviour specification facilitates precision in protocols and training materials by describing what should be done, by whom, when and where.
We found variation in the clinical components of SDD, in terms of the drug regimen, mode of drug delivery and specification of components between the two study sites. This may be appropriate and could be the result of local tailoring to make the intervention simple and feasible to deliver. Various behaviours directly related to drug provision as well as relevant to the SDD intervention (e.g. authorisation of SDD delivery) were performed by multiple clinicians in differing contexts. Overall, SDD implementation and delivery comprised the interrelated phases of SDD adoption, operationalisation, provision and surveillance.
Additional behaviours to those specified in documentation were identified. These behaviours are essential for SDD delivery. SDD involved a range of healthcare professionals performing various behaviours in differing contexts. These findings emerged from the interview and observational evidence but were not always clearly specified in the documentation. Ensuring that these additional behaviours are specified in protocols, guidelines and the academic literature should lead to improvements in implementation, delivery and reproducibility of SDD 2, 3 .
Various behaviours were identified in order to implement SDD, many at the organisational and team level and others at the individual level. Several features of operationalisation identified an on-going process (e.g. nurse training for SDD provision) due to staff turnover. SDD might be perceived as a simple and easy intervention from the individual behavioural perspective that becomes increasingly complex when focusing on the flow of actions required at an organisational level for its delivery in practice. Consequently, some of the barriers and facilitators to SDD provision tended to centre on the environmental context and resource issues, rather than specific attitudinal (e.g. beliefs about SDD effectiveness) or skills barriers. Clinicians in ICUs not delivering SDD might include different views potentially preventing SDD rollout, requiring further research in this area 18 .
Strengths and limitations
A limitation of this exploratory study is the potential lack of generalisability due to the use of only two sites. Additional clinical and behavioural components as well as alternative methods of SDD implementation and delivery may be evident if investigating SDD practice in a larger number of ICUs. However, the study was exploratory in nature with the goal of providing information-rich case studies that facilitate in-depth understanding of SDD in practice rather than a comprehensive picture of SDD across all UK ICUs. We recruited only one microbiologist, limiting the perspective from this profession. Lastly, clinicians in ICUs not delivering SDD may have different views about barriers to SDD implementation. This was investigated systematically in a larger programme of work 19 , but was beyond the remit of the study reported here.
Conclusion
This study is the first to develop a formal description of the full clinical and behavioural components of SDD and to describe how they impact on SDD implementation and delivery in practice. We identified a wide range of behaviours involved in delivering SDD, several of which were not included in local SDD protocols. Significant protocol adaptations resulting from these behaviours were observed across sites -supporting the need for routine behavioural specification in SDD delivery protocols. Such routine specification would greatly facilitate the subsequent detection of acceptable variations and those that might lead to significant differences in patient outcomes.
Competing interests
The authors declare that they have no competing interests. Note. X = identified within site; * = identified through interview, † = identified through observation 
